Recently Completed Funding
- National Institutes of Health – National Institute on Aging, SWAN: The Study of Women’s Health Across the Nation V
- National Institutes of Health – National Cancer Institute, A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
- National Institutes of Health – National Institute on Aging, Study of Women’s Health Across the Nation IV
- National Institutes of Health – National Institute on Aging, MsFLASH: Relative Efficacy of Hormonal and Non-Hormonal Interventions for Vasomotor Symptoms
- National Institutes of Health – National Institute of Mental Health, Defining the Mechanisms of Menopause-Associated Sleep and Mood Disturbance
- National Institutes of Health – National Cancer Institute, Role of Beta-endorphin in Cancer Therapy Induced Fatigue
- Sage Therapeutics, A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects with Moderate or Severe Postpartum Depression
- Merck Investigator Studies Program, Psychological and Autonomic Hyperarousal in Menopausal Hot Flash-Associated Insomnia
- Cephalon Pharmaceuticals, The Effect of Armodafinil (Nuvigil) on Quality of Life and Fatigue in Peri- and Postmenopausal Women
- Bayer Pharmaceuticals, Oral-contraceptive Pills to Treat Premenstrual Worsening of Depression
- Brigham and Women’s Hospital Award and Dana Farber Cancer Institute Award, Predicting Hot Flash and Quality of Life Response to Breast Cancer Therapies
